Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018

Matteis Paul Maintained (ACAD) at Hold with Decreased Target to $14 on, Aug 9th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-decreased-target-to-14-on-aug-9th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Matteis Paul of Stifel, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Decreased Target from $17 to $14 on, Aug 9th, 2018.

Matteis, nor any peers, have made any analyst calls on ACAD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30